Abstract

Abstract Tumor microenvironment favors tumor cells to promote tumor growth, migration, invasion, and angiogenesis. IL-1beta, one of the inflammatory cytokines associated with tumor microenvironment, plays an important role in the development and progress of tumor. The activation of inflammasome is critical to secrete mature IL-1beta through stepwise reactions to activate capspase-1. Therefore, we investigated whether the metastatic potential of breast cancer cells was regulated by NLRP3 inflammasome activation of macrophages in tumor microenvironment. The activation of NLRP3 inflammasome was induced by ATP in bone marrow-derived primary mouse macrophages. The metastatic potential of 4T1 breast cancer cells was determined by migration and invasion assays with transwell system. Conditioned media from ATP-stimulated wild-type macrophages increased the migration and invasion of breast cancer cells (4T1) while conditioned media from NLRP3 knockout macrophages stimulated with ATP failed to induce the migration and invasion of breast cancer cells. Celastrol, an inhibitor of NLRP3 inflammasome, reduced the potency of macrophages to stimulate the migration and invasion of 4T1 breast cancer cells. The suppression of NLRP3 inflammasome by celastrol was mediated by the blockade of potassium efflux. The results demonstrate that the activation of NLRP3 inflammasome in macrophages leads to the enhancement of metastatic potential of breast cancer cells. The results would provide a novel anticancer strategy to modulate tumor microenvironment by suppressing NLRP3 inflammasome and consequently reducing IL-1beta production. (This study was supported by the National Research Foundation of Korea (NRF) grants funded by the Korea government (Bio & Medical Technology Development Program, NRF-2017M3A9F5028608; Basic Research Laboratory Program, NRF-2017R1A4A1015036.) Citation Format: Jin Y. Lee, Hye E. Lee, Joo Y. Lee. The metastatic potential of breast cancer cells was suppressed by NLRP3 inflammasome inhibition in macrophages [abstract]. In: Proceedings of the AACR Special Conference: Advances in Breast Cancer Research; 2017 Oct 7-10; Hollywood, CA. Philadelphia (PA): AACR; Mol Cancer Res 2018;16(8_Suppl):Abstract nr A26.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call